Astera Labs Inc’s filing revealed that its Director ALBA MANUEL unloaded Company’s shares for reported $5.48 million on Dec 01 ’25. In the deal valued at $166.18 per share,33,000 shares were sold. As a result of this transaction, ALBA MANUEL now holds 352,863 shares worth roughly $51.14 million.
Then, ALBA MANUEL sold 150,000 shares, generating $24,927,221 in total proceeds. Upon selling the shares at $166.18, the Director now owns 1,574,498 shares.
Before that, MAR 2011 CHILDRENS TRUST U/A D bought 170,000 shares. Astera Labs Inc shares valued at $26,786,900 were divested by the Director at a price of $157.57 per share.
A number of analysts have revised their coverage, including BNP Paribas Exane’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. Northland Capital also remained covering ALAB and has increased its forecast on November 17, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. TD Cowen maintained its rating on November 05, 2025. It rated ALAB as “a Hold”.
Price Performance Review of ALAB
On Tuesday, Astera Labs Inc [NASDAQ:ALAB] saw its stock jump 0.89% to $144.94. Over the last five days, the stock has lost -13.25%. Astera Labs Inc shares have risen nearly 18.37% since the year began. Nevertheless, the stocks have risen 9.43% over the past one year. While a 52-week high of $262.90 was reached on 09/18/25, a 52-week low of $47.12 was recorded on 04/04/25.
Levels Of Support And Resistance For ALAB Stock
The 24-hour chart illustrates a support level at 141.28, which if violated will result in even more drops to 137.63. On the upside, there is a resistance level at 147.92. A further resistance level may holdings at 150.91.
How much short interest is there in Astera Labs Inc?
A steep rise in short interest was recorded in Astera Labs Inc stocks on 2025-11-28, growing by 3.68 million shares to a total of 12.08 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 8.4 million shares. There was a rise of 30.48%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 05, 2025 when Stifel resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $200.
